Jason T Yustein Selected Research

Chimeric Antigen Receptors

1/2021

Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason T Yustein Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 07/2010
9	Osteosarcoma (Osteogenic Sarcoma) 05/2021 - 07/2015
5	Neoplasm Metastasis (Metastasis) 05/2021 - 11/2017
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2021 - 11/2010
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Triple Negative Breast Neoplasms 12/2019
1	Hemangiosarcoma (Angiosarcoma) 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2017
1	Necrosis 11/2015
1	Rupture 07/2010
1	Carcinogenesis 02/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2007
1	Hematologic Neoplasms (Hematological Malignancy) 07/2007

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 05/2021 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2018
2	WD repeat containing planar cell polarity effectorIBA 05/2021 - 11/2016
2	Monoclonal AntibodiesIBA 05/2021 - 12/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 01/2020
2	CateninsIBA 01/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2019
2	EWS-FLI fusion proteinIBA 01/2020 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2017
1	Immune Checkpoint InhibitorsIBA 05/2021
1	Immunoglobulin G (IgG)IBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 05/2021
1	p21-Activated KinasesIBA 01/2021
1	ras ProteinsIBA 01/2021
1	PF 3758309IBA 01/2021
1	KPT-9274IBA 01/2021
1	InterferonsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	ponatinibIBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Drug CombinationsIBA 01/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	Long Noncoding RNAIBA 01/2019
1	Lactate Dehydrogenase 5IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Core Binding Factor Alpha 1 SubunitIBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010
1	YK 4-279IBA 11/2010
1	Aldehyde DehydrogenaseIBA 11/2010
1	Capsules (Microcapsules)IBA 07/2010
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2010
1	Biological ProductsIBA 07/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 12/2020 - 11/2010
5	Therapeutics 05/2021 - 08/2013
2	Immunotherapy 01/2022 - 01/2021
1	Radiotherapy 01/2018